PHIO
Phio Pharmaceuticals Corp.
Latest Form 4:Purchase$11KbyBitterman Robert J (Chairman, Pres. & CEO) · filed Aug 19, 2026
Phio Pharmaceuticals Corp. (PHIO) has 12 SEC Form 4 filings (12 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Aug 19, 2026.
The most active filer is Chairman, Pres. & CEO Bitterman Robert J with 6 filings.
- Industry:Biotechnology
- CEO:Robert L. Bitterman
- Employees:6
- HQ:Marlborough, MA, US
- IPO:2012-05-10
Insider Buying
$43K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
1
in the rolling window
Market Cap
$12.3M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| Chairman, Pres. & CEO | Purchase | 10,000 | $11K | Aug 19 | SEC ↗ | |
Bitterman Robert JFirst in 6 months | Chairman, Pres. & CEO | Purchase | 10,000 | $10K | Jun 29 | SEC ↗ |
| Chairman, Pres. & CEO | Purchase | 5,000 | $5K | Jan 2 | SEC ↗ | |
| Chairman, Pres. & CEO | Purchase | 5,000 | $5K | Dec 29 | SEC ↗ | |
| Chairman, Pres. & CEO | Purchase | 5,000 | $6K | Nov 24 | SEC ↗ | |
Bitterman Robert JFirst filing | Chairman, Pres. & CEO | Purchase | 5,000 | $6K | Nov 19 | SEC ↗ |
Related companies
Phio Pharmaceuticals Corp. is in the Healthcare sector.